Chargement en cours...
Preclinical and Coclinical Studies in Prostate Cancer
Men who develop metastatic castration-resistant prostate cancer (mCRPC) will invariably succumb to their disease. Thus there remains a pressing need for preclinical testing of new drugs and drug combinations for late-stage prostate cancer (PCa). Insights from the mCRPC genomic landscape have reveale...
Enregistré dans:
| Publié dans: | Cold Spring Harb Perspect Med |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Cold Spring Harbor Laboratory Press
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5880160/ https://ncbi.nlm.nih.gov/pubmed/29038335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/cshperspect.a030544 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|